Soleno Therapeutics to Participate in Upcoming June Conferences

Group 1 - Soleno Therapeutics, Inc. will participate in two upcoming investor conferences in June 2025, including the Jefferies Global Healthcare Conference and the Goldman Sachs 46 Healthcare Conference [1] - The Jefferies Global Healthcare Conference presentation is scheduled for June 4, 2025, at 10:30 AM ET, while the Goldman Sachs conference presentation will take place on June 10, 2025, at 8:40 AM ET [1] - Both presentations will be available for replay in the Investors section on the company's website [1] Group 2 - Soleno Therapeutics focuses on developing and commercializing novel therapeutics for rare diseases [2] - The company's first commercial product, VYKAT™ XR (diazoxide choline) extended-release tablets, is designed for treating hyperphagia in individuals with Prader-Willi syndrome aged four years and older [2]